Latham Group: Q3 Earnings Snapshot
Published Sat, 02 Nov 2024 12:31:37 GMT
LATHAM, N.Y. (AP) — LATHAM, N.Y. (AP) — Latham Group Inc. (SWIM) on Tuesday reported third-quarter profit of $6.2 million.On a per-share basis, the Latham, New York-based company said it had profit of 5 cents.The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 12 cents per share.The swimming pool maker posted revenue of $160.8 million in the period, which also fell short of Street forecasts. Three analysts surveyed by Zacks expected $162.6 million.Latham Group expects full-year revenue in the range of $555 million to $570 million._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SWIM at https://www.zacks.com/ap/SWIMSourceEvergy: Q3 Earnings Snapshot
Published Sat, 02 Nov 2024 12:31:37 GMT
KANSAS CITY, Mo. (AP) — KANSAS CITY, Mo. (AP) — Evergy, Inc. (EVRG) on Tuesday reported net income of $351.6 million in its third quarter.On a per-share basis, the Kansas City, Missouri-based company said it had net income of $1.53. Earnings, adjusted for non-recurring costs, came to $1.88 per share.The electric utility posted revenue of $1.67 billion in the period.Evergy expects full-year earnings in the range of $3.55 to $3.65 per share._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EVRG at https://www.zacks.com/ap/EVRGSourcePrecision BioSciences: Q3 Earnings Snapshot
Published Sat, 02 Nov 2024 12:31:37 GMT
DURHAM, N.C. (AP) — DURHAM, N.C. (AP) — Precision BioSciences Inc. (DTIL) on Tuesday reported a loss of $8.1 million in its third quarter.On a per-share basis, the Durham, North Carolina-based company said it had a loss of 7 cents. Losses, adjusted to account for discontinued operations, came to 10 cents per share.The genome editing company posted revenue of $13.1 million in the period._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DTIL at https://www.zacks.com/ap/DTILSourceEmerson Electric: Fiscal Q4 Earnings Snapshot
Published Sat, 02 Nov 2024 12:31:37 GMT
ST. LOUIS (AP) — ST. LOUIS (AP) — Emerson Electric Co. (EMR) on Tuesday reported fiscal fourth-quarter earnings of $744 million.The St. Louis-based company said it had profit of $1.29 per share.The results did not meet Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $1.30 per share.The maker of process controls systems, valves and analytical instruments posted revenue of $4.09 billion in the period, which also fell short of Street forecasts. Five analysts surveyed by Zacks expected $4.2 billion.For the year, the company reported profit of $13.22 billion, or $22.88 per share. Revenue was reported as $15.17 billion.For the current quarter ending in December, Emerson Electric expects its per-share earnings to range from $1 to $1.05. Analysts surveyed by Zacks had forecast adjusted earnings per share of $1.19.The company expects full-year earnings in the range of $5.15 to $5.35 per share._____This story was gener...Fidelity National: Q3 Earnings Snapshot
Published Sat, 02 Nov 2024 12:31:37 GMT
JACKSONVILLE, Fla. (AP) — JACKSONVILLE, Fla. (AP) — Fidelity National Information Services Inc. (FIS) on Tuesday reported a loss of $449 million in its third quarter.The Jacksonville, Florida-based company said it had a loss of 76 cents per share. Earnings, adjusted for one-time gains and costs, came to 94 cents per share.The results did not meet Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of $1.59 per share.The banking and payment technologies company posted revenue of $2.49 billion in the period, also missing Street forecasts. Eleven analysts surveyed by Zacks expected $3.65 billion.Fidelity National expects full-year revenue in the range of $14.6 billion to $14.65 billion._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FIS at https://www.zacks.com/ap/FISSourceAxoGen: Q3 Earnings Snapshot
Published Sat, 02 Nov 2024 12:31:37 GMT
ALACHUA, Fla. (AP) — ALACHUA, Fla. (AP) — AxoGen Inc. (AXGN) on Tuesday reported a loss of $4.1 million in its third quarter.On a per-share basis, the Alachua, Florida-based company said it had a loss of 10 cents. Earnings, adjusted for stock option expense, came to 1 cent per share.The regenerative medicine company posted revenue of $41.3 million in the period.AxoGen expects full-year revenue in the range of $154 million to $159 million.The company’s shares closed at $3.93. A year ago, they were trading at $11.03._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AXGN at https://www.zacks.com/ap/AXGNSourceDatadog: Q3 Earnings Snapshot
Published Sat, 02 Nov 2024 12:31:37 GMT
NEW YORK (AP) — NEW YORK (AP) — Datadog Inc. (DDOG) on Tuesday reported third-quarter profit of $22.6 million.The New York-based company said it had profit of 6 cents per share. Earnings, adjusted for stock option expense and amortization costs, were 45 cents per share.The results topped Wall Street expectations. The average estimate of 13 analysts surveyed by Zacks Investment Research was for earnings of 34 cents per share.The data analytics and cloud monitoring company posted revenue of $547.5 million in the period, also beating Street forecasts. Fourteen analysts surveyed by Zacks expected $523.3 million.For the current quarter ending in December, Datadog expects its per-share earnings to range from 42 cents to 44 cents.The company said it expects revenue in the range of $564 million to $568 million for the fiscal fourth quarter.Datadog expects full-year earnings in the range of $1.52 to $1.54 per share, with revenue ranging from $2.1 billion to $2.11 billion._____This story was ...Hostess Brands: Q3 Earnings Snapshot
Published Sat, 02 Nov 2024 12:31:37 GMT
LENEXA, Kan. (AP) — LENEXA, Kan. (AP) — Hostess Brands, Inc. (TWNK) on Tuesday reported third-quarter net income of $22.8 million.The Lenexa, Kansas-based company said it had net income of 17 cents per share. Earnings, adjusted for one-time gains and costs, were 24 cents per share.The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 27 cents per share.The company posted revenue of $352.8 million in the period, also falling short of Street forecasts. Five analysts surveyed by Zacks expected $366 million._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TWNK at https://www.zacks.com/ap/TWNKSourceDelek US Holdings: Q3 Earnings Snapshot
Published Sat, 02 Nov 2024 12:31:37 GMT
BRENTWOOD, Tenn. (AP) — BRENTWOOD, Tenn. (AP) — Delek US Holdings Inc. (DK) on Tuesday reported third-quarter net income of $128.7 million.The Brentwood, Tennessee-based company said it had profit of $1.97 per share. Earnings, adjusted for restructuring costs and non-recurring costs, were $2.02 per share.The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of $1.36 per share.The refinery operator posted revenue of $4.75 billion in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $3.97 billion._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DK at https://www.zacks.com/ap/DKSourceZevra Therapeutics: Q3 Earnings Snapshot
Published Sat, 02 Nov 2024 12:31:37 GMT
CELEBRATION, Fla. (AP) — CELEBRATION, Fla. (AP) — Zevra Therapeutics, Inc. (ZVRA) on Tuesday reported a loss of $14 million in its third quarter.The Celebration, Florida-based company said it had a loss of 40 cents per share.The specialty pharmaceutical company posted revenue of $2.9 million in the period._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ZVRA at https://www.zacks.com/ap/ZVRASourceLatest news
- Hundreds more tech, biotech layoffs hit Bay Area, Google real estate ally cuts jobs
- With La Niña officially over, El Niño will form during this hurricane season, forecasters say
- Opinion: Why venture capitalist believes Elizabeth Holmes should be freed
- Bay Area residents have 1 week until storm-related FEMA, SBA disaster relief deadline
- Two More Jan. 6 Capitol Rioters Have Fled Charges, Bringing Total to Six
- Fairfax County Board of Supervisors considering higher salaries for members
- China condemns Japanese plan to release Fukushima water
- Fire breaks out at building near White House, no injuries
- Man, teen dead after shooting in Southeast DC, 1 injured
- En EEUU se crearon 311,000 puestos de trabajo en febrero, pero sube la tasa de desempleo